Literature DB >> 3021879

Role of the Vi antigen of Salmonella typhi in resistance to host defense in vitro.

R J Looney, R T Steigbigel.   

Abstract

The virulence of Salmonella typhi is associated with the presence of the Vi antigen. Mechanisms of Vi antigen virulence were examined in vitro. The Vi antigen-containing strain Quailes was significantly (P less than 0.025) more resistant to lysis by nonimmune serum than S. typhi 0901, which does not have the Vi antigen, and resulted in less activation of complement by the alternative pathway (P less than 0.05). Human polymorphonuclear leukocytes (PMNs) ingested strain Quailes significantly (P less than 0.01) more slowly and less completely than strain 0901 as assessed by three measures of phagocytic rate. In contrast to prior reports, the Vi antigen did not prevent an oxidative burst, measured by O2- production, chemiluminescence, and O2 consumption. The extent of the oxidative burst correlated directly and closely with the rate of phagocytosis. When the rate of PMN phagocytosis for both strains was equalized by opsonizing strain 0901 with 1% and strain Quailes with a 3% concentration of serum, the PMN oxidative burst was equal. C3 binding to strain Quailes was significantly (P less than 0.005) less than to strain 0901. Hence the Vi antigen inhibited phagocytosis by preventing C3b binding and solely as a consequence of this induced a lesser PMN oxidative burst. Furthermore, strain Quailes was significantly (P less than 0.025) less susceptible to killing by H2O2 than strain 0901. To ensure that these observations were a consequence of the Vi antigen and not other strain differences, another pair of S. typhi with and without the Vi antigen were similarly compared, and the results were the same as with strains Quailes and 0901. Strains 0901 and Quailes were killed by PMNs from a patient with chronic granulomatous disease but more slowly than by normal PMNs, indicating that S. typhi is susceptible to nonoxidative killing.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021879

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  30 in total

1.  Genetic determinants of immune-response to a polysaccharide vaccine for typhoid.

Authors:  Partha P Majumder; Herman F Staats; Neeta Sarkar-Roy; Binuja Varma; Trina Ghosh; Sujit Maiti; K Narayanasamy; Carol C Whisnant; James L Stephenson; Diane K Wagener
Journal:  Hugo J       Date:  2010-03-11

Review 2.  Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis.

Authors:  Manuela Raffatellu; Daniela Chessa; R Paul Wilson; Cagla Tükel; Mustafa Akçelik; Andreas J Bäumler
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  The Vi capsular polysaccharide prevents complement receptor 3-mediated clearance of Salmonella enterica serotype Typhi.

Authors:  R Paul Wilson; Sebastian E Winter; Alanna M Spees; Maria G Winter; Jessalyn H Nishimori; Jesus F Sanchez; Sean-Paul Nuccio; Robert W Crawford; Çagla Tükel; Andreas J Bäumler
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

Review 4.  Now you see me, now you don't: the interaction of Salmonella with innate immune receptors.

Authors:  A Marijke Keestra-Gounder; Renée M Tsolis; Andreas J Bäumler
Journal:  Nat Rev Microbiol       Date:  2015-03-09       Impact factor: 60.633

Review 5.  Typhoid fever: "you can't hit what you can't see".

Authors:  Tamding Wangdi; Sebastian E Winter; Andreas J Bäumler
Journal:  Gut Microbes       Date:  2012-03-01

6.  Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses.

Authors:  Amita Sharma; Ayub Qadri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

7.  Vi antigen expression in Salmonella enterica serovar Typhi clinical isolates from Pakistan.

Authors:  John Wain; Deborah House; Afia Zafar; Stephen Baker; Satheesh Nair; Claire Kidgell; Zulfiqar Bhutta; Gordon Dougan; Rumina Hasan
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

8.  Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.

Authors:  Huoying Shi; Javier Santander; Karen E Brenneman; Soo-Young Wanda; Shifeng Wang; Patti Senechal; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

9.  A genomewide mutagenesis screen identifies multiple genes contributing to Vi capsular expression in Salmonella enterica serovar Typhi.

Authors:  Derek Pickard; Robert A Kingsley; Christine Hale; Keith Turner; Karthikeyan Sivaraman; Michael Wetter; Gemma Langridge; Gordon Dougan
Journal:  J Bacteriol       Date:  2013-01-11       Impact factor: 3.490

10.  The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity.

Authors:  Sebastian E Winter; Maria G Winter; Parameth Thiennimitr; Valerie A Gerriets; Sean-Paul Nuccio; Holger Rüssmann; Andreas J Bäumler
Journal:  Mol Microbiol       Date:  2009-08-24       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.